- Home
- GCV vs SRTS Comparison
GCV vs SRTS Comparison
Compare GCV & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCV
- SRTS
- Stock Information
- Founded
- GCV 1988
- SRTS 2010
- Country
- GCV United States
- SRTS United States
- Employees
- GCV N/A
- SRTS N/A
- Industry
- GCV Finance/Investors Services
- SRTS Medical/Dental Instruments
- Sector
- GCV Finance
- SRTS Health Care
- Exchange
- GCV Nasdaq
- SRTS Nasdaq
- Market Cap
- GCV 79.7M
- SRTS 75.5M
- IPO Year
- GCV N/A
- SRTS 2016
- Fundamental
- Price
- GCV $4.10
- SRTS $3.17
- Analyst Decision
- GCV
- SRTS Strong Buy
- Analyst Count
- GCV 0
- SRTS 3
- Target Price
- GCV N/A
- SRTS $8.00
- AVG Volume (30 Days)
- GCV 57.9K
- SRTS 84.3K
- Earning Date
- GCV 01-01-0001
- SRTS 11-13-2025
- Dividend Yield
- GCV 13.04%
- SRTS N/A
- EPS Growth
- GCV N/A
- SRTS N/A
- EPS
- GCV N/A
- SRTS N/A
- Revenue
- GCV N/A
- SRTS $37,564,000.00
- Revenue This Year
- GCV N/A
- SRTS N/A
- Revenue Next Year
- GCV N/A
- SRTS $33.38
- P/E Ratio
- GCV N/A
- SRTS N/A
- Revenue Growth
- GCV N/A
- SRTS 3.29
- 52 Week Low
- GCV $3.15
- SRTS $3.03
- 52 Week High
- GCV $4.58
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- GCV 54.17
- SRTS 49.20
- Support Level
- GCV $4.00
- SRTS N/A
- Resistance Level
- GCV $4.28
- SRTS $3.29
- Average True Range (ATR)
- GCV 0.04
- SRTS 0.12
- MACD
- GCV 0.00
- SRTS -0.07
- Stochastic Oscillator
- GCV 33.93
- SRTS 90.98
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.